The SEC Files Say Defense Contractors Have No R&D Budget

Stansberry Venture Technology editor Dave Lashmet returns to the show. He's our go-to for anything and everything related to emerging technologies. 

Whether it's the ongoing Russia-Ukraine war... more nuclear threats from North Korea... or the Chinese spy balloon fiasco... geopolitics has already become 2023's overarching theme. It's also why Dave is bullish on one corner of the market in particular...

"The simple thesis is that we don't know what 2023 will be like for investors – if it'll be a bear, a bull, or a sideways market. But what we do know is that the best way to play defense in 2023 is going to be to buy defense stocks."

Dave also shares one company's stock that is poised to soar thanks to its groundbreaking new stealth technology. And just like other defense stocks on Dave's radar, it has a "very, very, very long [tail]" and "monopolies [on technologies]." Plus, Dave also details exactly what he looks for when screening military tech stocks, along with his "secret decoder ring" for choosing pharmaceutical companies to invest in.